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2020 developments in the provision of early medical abortion by 1 




The COVID-19 pandemic has necessitated the rapid implementation of telemedical health services. In 6 
the United Kingdom, one service that has benefitted from this response is the provision of early medical 7 
abortion. England, Wales, and Scotland have all issued approval orders to this effect. These orders allow 8 
women to terminate pregnancies up to certain gestational limits, removing the need for them to 9 
contravene social distancing measures to access care. However, they are intended only as temporary 10 
measures for the duration of the pandemic response. In this paper, we chart these developments and 11 
further demonstrate the already acknowledged politicisation of abortion care. We focus on two key 12 
elements of the orders: (1) the addition of updated clinical guidance in the Scottish order that suggests 13 
an extended gestational limit, and (2) sunset clauses in the English and Welsh orders, as well as an 14 
indication of similar intentions in Scotland. In discussing these two issues, we suggest that the refusal 15 
of UK governments to introduce telemedical provision of early medical abortion previously has not 16 
been based on health concerns. Further, we question whether it would be appropriate for the approval 17 
orders to be lifted following the pandemic, suggesting that to do so would represent regressive and 18 
harmful policy. 19 
 20 
 21 
1.0 Introduction 22 
 23 
As a result of the COVID-19 pandemic, the use of telemedicine throughout the United Kingdom’s (UK) 24 
National Health Service (NHS) has quickly increased as a means of allowing patients to continue to 25 
access care without having to contravene social distancing measures and unnecessarily risk exposure to 26 
COVID-19. One area where telemedicine has been introduced is in the provision of early medical 27 
abortion (EMA). 28 
 29 
In the past few years, the UK has seen long overdue moves to permit home use of the second drug 30 
required for an EMA [1]. The governments of Scotland [2], Wales [3], and England [4] – in that order 31 
– issued approval orders between 2017 and 2018 to permit women to take the second drug required for 32 
an EMA at home provided that the first was taken under clinical supervision. At the time, and indeed 33 
long before, there had been calls to allow women to take both drugs at home after having them 34 
prescribed remotely [1, 5]. So-called telemedical EMA (TEMA) is a means of removing barriers to 35 
abortion care and has therefore been argued for in order to ensure equality in access to care [5, 6]. 36 
Notably, the National Institute for Health and Care Excellence (NICE) in England and Wales 37 
recommends the use of telemedicine in abortion care in its 2019 guidelines [7]. 38 
 39 
In response to the COVID-19 pandemic, telemedicine has seen increased implementation throughout 40 
the NHS [8]. Whilst behind others, as of late March 2020 abortion was added to the list of services to 41 
benefit from telemedicine during the pandemic, starting with a TEMA approval order in England. 42 
TEMA is now formally provided for in England, Wales, and Scotland. In Northern Ireland, however, 43 
provision is informal, and potentially problematic given that it remains unlawful in most circumstances. 44 
 45 
In this paper, we outline the development of these policy changes. We first describe both EMA and 46 
TEMA, before providing a chronological overview of changes. Beginning with the twice reversed 47 
decision in England, we discuss the nature of the introduction of TEMA in both Wales and Scotland; 48 
the former mirroring England whilst the latter departs from Westminster on two important points. The 49 
far more complicated situation in Northern Ireland is then considered, followed by a look at the statistics 50 
thus far and a brief comparative discussion in which we look to the response of the United States (US). 51 
Finally, the implications – both short- and long-term – for questions of access to abortion care are 52 
discussed, demonstrating how this apparently progressive change is merely a supporting measure in the 53 
wider fight against COVID-19 which will in fact further undermine the reproductive rights of women 54 
in future. 55 
 56 
2.0 TEMA explained 57 
 58 
2.1 Early medical abortion 59 
 60 
EMA requires the use of mifepristone followed, 24-48 hours later, by misoprostol. The result is an 61 
induced miscarriage followed by the expulsion of the products of conception. The World Health 62 
Organization (WHO) makes a ‘strong’ recommendation for this procedure to be used up to nine weeks’ 63 
gestation [9]. The WHO also notes that the same drugs may be used to terminate a pregnancy at a later 64 
gestational stage, though with the caution that there are limited data for EMAs performed between nine- 65 
and 12-weeks’ gestation [9]. NICE recommends a slightly higher limit of 10 weeks’ gestation [7], but 66 
both fall within the bracket of what has been indicated as likely safe and effective in the absence of 67 
randomised clinical trials [10]. 68 
 69 
2.2 The introduction of telemedicine 70 
 71 
Whilst only a recent development in the UK, various forms of TEMA has been practiced in some parts 72 
of the world for more than a decade. Planned Parenthood of the Heartlands set up such a service in Iowa 73 
in 2008 which allowed women to attend a collaborating clinic with no on-site physician, undergo a 74 
videoconference consultation with an off-site physician, and have the necessary medications dispensed 75 
by the collaborating clinic if prescribed [11]. This did require women to physically attend a clinic, but 76 
it improved access by enabling clinics that previously could not provide EMAs to do so. Another 77 
example from the US is the TelAbortion Project which has, since 2016, enabled women in several states 78 
to be posted abortion medications after obtaining screening tests locally [12]. Similarly to what was 79 
offered by Planned Parenthood of the Heartlands, access is improved even though those using the 80 
services of the TelAbortion Project are still required to attend some form of medical facility. 81 
 82 
A different model – closer to what is often envisioned when TEMA is mentioned – is that of Women 83 
on Web. This service has been operating internationally since 2004, though is available only to those in 84 
countries where safe access to abortion is not possible [13]. Unlike the previous two services outlined, 85 
Women on Web operates entirely online. An online question-based consultation is completed and, if 86 
the responses indicate that EMA is appropriate, the medications are sent to the woman by post. This 87 
system, then, has greater potential to improve access to abortion care as there is no need to attend a 88 
facility in person. 89 
 90 
The safety, effectiveness, and acceptability of TEMA have previously been demonstrated. Endler and 91 
colleagues have highlighted, through a systematic review, that there are similar rates of ‘complete 92 
abortion, continuing pregnancy, hospitalization, and blood transfusion’ following both TEMA and in-93 
clinic EMA [10]. They also found that both women and providers found TEMA highly acceptable. It 94 
should be noted, however, that Endler and colleagues’ review does rate the quality of evidence as low, 95 
so must be taken as more indicative than conclusive. In addition to the evidence supporting the abortion 96 
itself during TEMA, it has also been demonstrated that women can reliably date their pregnancies 97 
according to their menstrual history, thereby minimising the risk of them undergoing an EMA at a later 98 
gestational stage. A study between the US and India found that only 9.8-10% (woman’s estimate based 99 
on last menstrual period) and 3.4-7.7% (woman’s estimate based on date of last unprotected intercourse) 100 
of women fell within the ‘caution zone’, which was defined as the woman dating her pregnancy at <9 101 
weeks but her healthcare provider dating it at ≥9 weeks [14]. 102 
 103 
3.0 TEMA developments in the UK 104 
 105 
3.1 England 106 
 107 
The first country in the UK to instigate TEMA in response to the COVID-19 threat was England (see 108 
Table 1). In contrast, England did not permit home use of misoprostol until after Scotland and Wales 109 
[1]. However, the process resulting in the policy was unclear and initially caused widespread criticism 110 
and confusion. 111 
 112 
On the 23rd March 2020, the UK Department for Health and Social Care issued an approval order 113 
allowing women seeking an EMA in England to self-administer both necessary medications at home. 114 
The order specified that following a consultation with an appropriate provider via electronic means, a 115 
woman may be prescribed both mifepristone and misoprostol. However, the order was revoked later 116 
that same day, replaced online by a statement that it had been published in error [15]. This led to a great 117 
deal of uncertainty, which was especially troubling for women seeking abortions at the time. As a result, 118 
an open letter was sent to Matt Hancock, the Secretary of State for Health and Social Care, on the 28th 119 
March 2020 by a group of public health specialists [16]. This letter noted the scientific evidence and 120 
advice of professionals which had been ignored and called for the order to be reinstated. 121 
 122 
Following this letter, a second order relaxing abortion regulations in England was issued on the 30th 123 
March 2020. This second order was similar in allowing women to be prescribed both medications 124 
following remote consultation, with a gestational limit of nine weeks and six days [17]. However, it 125 
differed in its inclusion of a sunset clause; the order will expire automatically on the 30th March 2022, 126 
or with the expiration of the Coronavirus Act 2020 if that comes first. That the order is temporary might 127 
be perceived as problematic, as will be explored shortly. 128 
 129 
On the 6th July 2020, it was announced in the House of Commons that a public consultation will take 130 
place on whether to make the temporary provisions permanent. In response to a question posed, the 131 
Minister for Safeguarding, Victoria Atkins, confirmed that the temporary provisions would at least stay 132 
in place ‘until the public consultation concludes and a decision has been made’ [18]. 133 
 134 
 135 
3.2 Wales 136 
 137 
Just one day later – on the 31st March 2020 – both Wales and Scotland followed suit. Scotland will be 138 
discussed shortly, so for now we will focus on Wales. 139 
 140 
The Welsh approval order was issued by Vaughan Gething, the Welsh Minister for Health and Social 141 
Services, to supersede the previous order of the 27th June 2018 [3] which permitted home use of 142 
misoprostol. In almost entirely replicating the earlier English order, the Welsh approval expires either 143 
with the expiration of the Coronavirus Act 2020 or two years after the date of the approval (in this case 144 
the 31st March 2022) [19]. Again, following the English example, the gestational limit remains at nine 145 
weeks and six days in Wales. 146 
 147 
3.3 Scotland 148 
 149 
As noted above, Scotland also permitted TEMA on the 31st March 2020 [20]. The approval was similar 150 
to those of England and Wales in permitting home use of mifepristone (in addition to misoprostol as 151 
previously allowed) following remote consultation. However, it differs in two important respects: 152 
guidance on gestational limit and expiration. 153 
 154 
First, unlike the orders of England and Wales, the Scottish order does not contain an explicit gestational 155 
limit for TEMA. It is, however, accompanied by an annex containing guidance from Scottish Abortion 156 
Care Providers (the Scottish branch of the British Society of Abortion Care Providers) that includes 157 
gestational limits. This annexed document does not form a part of the approval order. Nonetheless, the 158 
Scottish Court of Session confirmed that whilst similar guidance in relation to the Scottish 2017 159 
approval order of home use of misoprostol was advisory only, practitioners should take the guidance 160 
into account [21].  In the annexed guidance to the Scottish 2020 approval order, providers are advised 161 
that a woman should be eligible for TEMA provided she has not exceeded 11 weeks and six days’ 162 
gestation [20]. This is a two week increase on the limit stipulated in the approval orders of England and 163 
Wales. It is also a two week increase on Scotland’s own previous limit as per the 2017 order regarding 164 
the home use of misoprostol [2]. 165 
 166 
Second, there is no included expiration of the order. Whereas the approvals in England and Wales will 167 
automatically expire unless further action is taken, the explanatory note attached to the Scottish order 168 
merely states: ‘we intend that it will have effect for a limited period so would revoke it and replace it 169 
with the terms of the previous approval (dated October 2017) at an appropriate time when it is judged 170 
that it is no longer necessary in relation to the pandemic response’ [20]. It is, then, possible that Scotland 171 
will maintain TEMA provisions permanently following the pandemic. At the very least, TEMA will not 172 
automatically become unlawful once the pandemic is over. Like England, Scotland is conducting a 173 
public consultation on the matter [22]. 174 
 175 
3.4 Northern Ireland 176 
 177 
Northern Ireland has consistently fallen behind the rest of the UK in increasing abortion access, with 178 
EMA only becoming lawful in the country on the 21st October 2019 following the failure of the Northern 179 
Ireland Assembly to reform; this failure resulted in the enactment of the Northern Ireland (Executive 180 
Formation etc) Act 2019, which decriminalised abortion in Northern Ireland. The purpose of this 181 
legislation was to bring Northern Ireland in line with the rest of the UK in allowing access to abortion 182 
[23]. It is important to note that the changed law in Northern Ireland remains very different to the rest 183 
of the UK. In England, Wales, and Scotland abortion remains a criminal offence and is lawful only 184 
when performed in compliance with the requirements of the Abortion Act 1967. Abortion is not a 185 
criminal offence in Northern Ireland, and the Abortion Act 1967 does not apply. On the 31st March 186 
2020, the Abortion (Northern Ireland) Regulations 2020, issued by the UK government, came into force 187 
to regulate the provision of care in Northern Ireland. The regulations were then revoked on the 14th May 188 
2020, when they were replaced by the Abortion (Northern Ireland) (No. 2) Regulations 2020. On the 189 
points of relevance to our discussion, both sets of regulations are the same. 190 
 191 
In listing the places where care may be provided in Northern Ireland the 2020 regulations are explicit 192 
that it must be provided in a hospital, clinic provided by a health and social care trust, premises used to 193 
provide primary medical services, or at home where referring to the second abortion medication in EMA 194 
[24]. The order also specifies that the Department of Health in Northern Ireland ‘may, for the purposes 195 
of these Regulations, approve a place for the carrying out of terminations’ [24]. Therefore, the same 196 
powers for approval orders relating to abortion provision are devolved to Northern Ireland as is the case 197 
for both Wales and Scotland. Despite calls from campaigning groups in Northern Ireland Robin Swann, 198 
the current Health Minister in Northern Ireland, has consistently resisted the call to issue approval for 199 
TEMA in Northern Ireland. However, organisations providing TEMA elsewhere in the UK are making 200 
their services available to women in Northern Ireland at this time [25]. 201 
 202 
 203 
4.0 Implications for access to abortion care 204 
 205 
For those who have long called for the introduction of TEMA in the UK, you might expect the changes 206 
we have discussed to be welcomed. Indeed, it is acknowledged as a step in the right direction [26]. 207 
However, the presence of a sunset clause in both the English and Welsh orders, as well as an indication 208 
of similar intentions in Scotland, limits the extent to which campaigners might view them as successes. 209 
 210 
That UK governments would permit TEMA at all suggests that it satisfies their standards of safety and 211 
effectiveness, as per guidelines from NICE that recommend considering providing abortion assessments 212 
by phone or video call (these guidelines do only apply in England and Wales) [7]. Of course, the changes 213 
will have largely been guided by a shift in the balance of risks and benefits; delivering abortion care 214 
remotely minimises the risk of COVID-19 infection in those concerned. Whilst there have been several 215 
studies demonstrating the safety, effectiveness, and acceptability of TEMA, as already noted the quality 216 
of evidence is not high [10]. A such, even though there is sufficient evidence to indicate that TEMA 217 
should at least be tried, it is not surprising that there has been no rush by politicians to permit it. 218 
However, now that TEMA is permitted, it is feasible that health concerns will soon no longer constitute 219 
a valid reason for caution. Provided there is no notable increase in adverse outcomes, the health concern 220 
argument will be weakened by the experience of TEMA. That being the case, the risks associated with 221 
removing the approval for TEMA – notably barriers to access resulting in treatment being 222 
delayed/prevented – may be avoided. 223 
 224 
It is also worth considering Scotland’s departure from both England and Wales in providing guidance 225 
that recommends an extension of the gestational limit for EMA with its TEMA approval order. As 226 
already noted, it is generally understood that TEMA within these additional two weeks raises no major 227 
cause for concern [10]. However, Scotland did depart from the status quo at the time. It can reasonably 228 
be assumed that the justification for the raised gestational limit was to increase the number of women 229 
eligible for TEMA during the pandemic, thereby further reducing the number of individuals at risk of 230 
infection by physically attending abortion clinics. However, similarly to the issue of sunset clauses, it 231 
may be difficult to return to the lower limit again after the pandemic as, provided TEMAs that take 232 
place during this two week window prove to be safe, effective, and acceptable, the health concerns 233 
argument will be weakened. Indeed, pressure is likely to mount on both England and Wales (perhaps 234 
even Northern Ireland) to also raise their gestational limits for (T)EMA. 235 
 236 
Finally, a possible concern with TEMA is that counselling may be inadequate, and proper disclosure of 237 
risks may not take place. If this were the case, there would be a justified concern. However, it is not the 238 
case – or at least it is not necessarily the case. Adequate counselling and proper disclosure of risks are 239 
possible in the context of telemedicine, and there need only be appropriate protocols in place (as there 240 
are with in-person delivery of abortion care) to ensure them. 241 
 242 
 243 
5.0 Early data on TEMA in England and Wales 244 
 245 
The Department of Health and Social Care released statistics in September 2020 that provide an 246 
overview of the initial months of TEMA in England and Wales [27]. It is necessary to highlight that 247 
these statistics cover England and Wales only and cover the period up to and including June 2020. 248 
Further, when breaking the data down into methods of abortion there is no explicit TEMA category. 249 
There are data on the number of medical abortions where both medications were taken at home, which 250 
it is reasonable to assume are largely the result of remote consultation and prescription. It is, however, 251 
possible that some of the abortions included in this categorisation were the result of both medications 252 
being taken home from an in-person consultation. 253 
 254 
There are two key points to be drawn from these statistics. First, we can infer that uptake of TEMA in 255 
England and Wales has been significant. The percentage of total abortions carried out medically in the 256 
period January to June 2020 was 82%, an increase from 72% in the same period in 2019 [27]. In the 257 
period April to June 2020, 43% of medical abortions involved both medications being self-administered 258 
at home, with this figure gradually increasing within this period. As noted above, some of those included 259 
in this 43% might not have been TEMA, but it is likely that the majority were, in part because of 260 
temporary clinic closures [28]. 261 
 262 
Second, there was a significant shift to abortions being carried out at earlier gestational ages. Abortions 263 
performed at under 10 weeks accounted for 86% of total abortions in the period of January to June 264 
2020, compared with 81% in the same period in 2019 [27]. A more notable change is in the percentage 265 
of abortions performed before 7 weeks, rising from 40% in the period January to June 2019 to 50% in 266 
the same period in 2020 [27]. A plausible explanation for these changes is the introduction of TEMA; 267 
not having to make arrangements to attend a clinic in person allows women to access abortion services 268 
earlier. Assuming this is true, the case for TEMA is strengthened. 269 
 270 
These statistics cover only the first three months in which TEMA was permitted in England and Wales, 271 
so conclusions cannot yet be reliably drawn. That we are still within pandemic circumstances also limits 272 
the feasibility of an accurate assessment. Nonetheless, these early figures at least suggest that the 273 
temporary approvals have been a success and have the potential to improve access in the long term. The 274 
experience of TEMA throughout the UK will also likely provide useful data for evaluating the safety, 275 
effectiveness, and acceptability of the specific model of delivery that has been implemented, but such 276 
data has not yet been published. 277 
 278 
 279 
6.0 A note on the United States 280 
 281 
Whilst our focus in this paper has been the UK, it is worth drawing a brief comparison to the US. Like 282 
the UK, several US states have responded to the COVID-19 pandemic by reassessing abortion 283 
provision. However, unlike the UK, where there have been changes these have been in the opposite 284 
direction with access to abortion being denied. 285 
 286 
Abortion is legal in the US [29], however individual states are empowered to introduce whatever 287 
regulatory framework surrounding abortion that they see fit provided it does not constitute an ‘undue 288 
burden’ on women’s access to care before foetal viability [30]. Following this a number of states, before 289 
the pandemic, introduced bans on TEMA; or effectively banned TEMA by the introduction of 290 
requirements such as examination before treatment provision or that a practitioner must supervise care. 291 
The Ohio Senate, however, only moved to ban TEMA on the 4th March 2020, as it was becoming 292 
increasingly evident that TEMA might be important as a measure to respond to the current crisis.  293 
 294 
Moreover, in response to the crisis state governors across the US introduced executive orders mandating 295 
the cessation of non-essential medical care. In some states, notably where TEMA was already unlawful, 296 
including Texas [31] and Ohio [32], state administration was clear that they did not believe abortion to 297 
be an essential medical service and, therefore, service provision must stop. Similar orders were issued 298 
in Alabama, Alaska, Arkansas, Indiana, Iowa, Louisiana, Mississippi, Oklahoma, Tennessee and West 299 
Virginia. Many of these orders have been successfully challenged in state courts. In Texas, after legal 300 
proceedings issued by Planned Parenthood and the Center for Reproductive Rights [33], the order has 301 
been lifted and clinics are now able to continue to operate provided they do not claim personal protective 302 
equipment assistance from authorities [34]. In many states, even where there has not yet been a 303 
successful legal challenge, clinics have vowed to remain open and continue to provide care [35]. The 304 
clear and deliberate attempt to effectively ban abortion that can be seen across the US illustrates how 305 
state governments have attempted to use the pandemic to interfere with abortion rights. In the UK, it is 306 
fortunate that the government has sought to act to ensure access in the circumstances – even if the 307 
measures introduced are also political in nature. The differing political responses can be accounted for 308 
by the differing socio-political contexts and legal traditions regarding abortion in the UK and the US 309 
[6]. In the US, abortion has become a prominent political issue because it is recognised as part of a 310 
woman’s constitutional right to privacy [36]. Whereas in the UK (except Northern Ireland), the 311 
Abortion Act 1967 has succeeded to some extent in ‘depoliticising’ abortion by entrenching a medical 312 
framework for provision in the law [37].  That there was a medical case, based on a shift in perceptions 313 
about the risks of TEMA in the COVID context, may be why the UK government were willing to make 314 
changes that improved access for women.   315 
 316 
 317 
7.0 Conclusion 318 
 319 
The introduction of TEMA in the UK will save thousands of women from coming to harm both during 320 
social distancing measures and after [6]. However, the extent to which it can be considered a success 321 
for women’s reproductive and sexual health and rights is limited by the fact that: in England and Wales 322 
these measures are only temporary; in Scotland the measures are intended to be temporary; and in 323 
Northern Ireland TEMA, strictly speaking, remains unlawful in most circumstances and is only 324 
accessible because providers have chosen to risk any potential legal consequences of providing care. 325 
 326 
That is not to detract from the fact that allowing TEMA in these circumstances is a move in the right 327 
direction in terms of evidence-based medicine. With temporary measures in place, further pressure on 328 
the governments of the UK may result in further approval orders which add permanence to TEMA 329 
provision. Indeed, the public consultations in England and Scotland may do just this. It would, we 330 
suggest, be appropriate for these temporary measures to be made permanent, and we call on UK 331 
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